Practicalities of nutrition support in chronic liver disease

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 3, Issue 3, 2000, Pages 227-229

  Gopalan, Sarath ^a,b   Saran, Shailee ^b   Sengupta, Raikamal ^b  

^a Pushpawati Singhania Research Institute   (India)

^b Nutrition Foundation of India   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BRANCHED CHAIN AMINO ACID; CHOLINE;

CHRONIC LIVER DISEASE; ENTERIC FEEDING; HEPATITIS VIRUS; HUMAN; LIVER TRANSPLANTATION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; REVIEW;

CHRONIC DISEASE; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 0033930926     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200005000-00011     Document Type: Review

References (21)

1. Nompleggi DJ, Bonkovsky HL. Nutritional supplementation in chronic liver disease: an analytical review. Hepatology 1994; 19:518-533.
2. Thaluvath PI, Triger DR. Evaluation of nutritional status by using anthropometry in adults with alcoholic and non-alcoholic liver disease. Am J Clin Nutr 1994; 60:269-273.
3. Gasull MA. Nutritional support in chronic liver disease. Eur J Gastroenterol Hepatol 1995; 7:528-532.
4. Kearns PP, Young H, Garura G, Blaschke T, O'Hanlon G, Rinki M, et al. Accelerated improvement of alcoholic liver disease with enteral nutrition. Gastroenterology 1992; 102:200-205.
5. McGhee RD, Henderson JM, Millikan Jr WJ, Bleier JL, Vogel R, Kassuony M, Rudman D. Comparison of the effects of hepatic-aid and a casein modular diet on encephalopathy, plasma amino acids and nitrogen balance in cirrhotic patients. Ann Surg 1997; 197:288-293.
6. Keohane PP, Attrill H, Gimble G, Spiller R, Frost P, Silk DBA. Enteral nutrition in malnourished patients with hepatic cirrhosis and acute encephalopathy. JPEN 1983, 7:345-350.
7. Falambos JT, Hersch T, Fulenwider JT, Ansley JD, Rudman D. Hyperalimentation in alcoholic patients. Am J Gastroenterol 1979; 72:535-541.
8. Smith J, Horowitz J, Henderson JM, Heymsfield S. Enteral hyperalimentation in undernourished patients with cirrhosis and ascites. Am J Clin Nutr 1982; 35:67-72.
9. Simko V. Long-term tolerance of a special amino acid oral formula in patients with advanced liver disease. Nutr Rep lnt 1983; 27:765-773.
10. Mendenhall C, Bongiovanni G, Goldberg S, Miller B, Rouster S, Schneider D, Tamburo C, et al. VA cooperative study on alcoholic hepatitis ill patients: changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutrition therapy. JPEN 1985; 9:590-596.
11. Christie ML, Sack DM, Pomposelli J, Horst D. Enriched branched-chain amino acid formula versus a casein-based supplement in the treatment of cirrhosis. JPEN 1985; 9:671-678.
12. Kawamura-Yasui N, Kaito M, Nakagawa N, Fujita N, Ikoma J, Gabazza EC, et al. Evaluating response to nutritional therapy using the branched-chain amino acid tyrosine ratio in patients with chronic liver disease. J Clin Lab Anal 1999; 13:31-34. The BCAA:tyrosine ratio is a very useful objective parameter to assess severity of hepatic parenchymal damage in CLD.
13. Novy MA, Schwarz KB. Nutritional considerations and management of the child with liver disease. Nutrition 1997; 13:177-184.
14. Protheroe SM. Feeding the child with chronic liver disease. Nutrition 1998; 14:796-800.
15. Jmelnitzky AC. New suggestions for the management of alcoholic liver diseases. Acta Gastroenterol Latinoam 1995; 25:73-84.
16. Liber CS. Susceptibility to alcohol related liver injury. Alcohol Suppl 1994; 2:315-326.
17. Wright PD, Holdsworth JD, Dionigi P, Clague MB, James OFW. Effect of branched-chain amino acid infusions on body protein metabolism in cirrhosis of liver. Gut 1986; 27(Suppl 1):96-102.
18. Misra S, Ament ME, Vargas JH, Scoff C, Reyen L, Herzog F. Chronic liver disease in children on long-term parenteral nutrition. J Gastroenterol Hepatol 1996; 11:54-56.
19. Beau P, Labat-Labourdette I, Ingrand P, Beauchant M. Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease? J Hepatol 1994; 20:240-244.
20. Maes M, Sokal E, Otte JB. Growth factors in children with end-stage liver disease before and after transplantation: a review. Pediatr Transplant 1997; 1:171-175.
21. Maghnie M, Barreca A, Ventura M, Tinelli C. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanism of growth retardation of children with inherited liver disorders. Clin Endocrinol (Oxf) 1998; 48:747-755.